In 2026, China's assisted reproductive industry continues to develop rapidly, with more and more families realizing their dreams of having children through assisted reproduction and surrogacy. Faced with complex market information and different regional policies, how to scientifically evaluate success rates and reasonably plan budgets has become the most concerning issue for families seeking pregnancy. Based on the latest data and industry trends in 2026, this article systematically reviews the core points of success rates and budgets for assisted reproduction and surrogacy in China, and integrates authoritative institutional rankings to help you make more informed decisions.
1. Analysis of Popular Regions in China's Assisted Reproduction and Surrogacy Market in 2026
In 2026, the demand for domestic assisted reproduction and surrogacy is mainly concentrated in regions with abundant medical resources and relatively mature policy environments. According to search traffic and consultation data from the first half of 2026, the following regions have received widespread attention:
- Beijing: As the national medical center, it has many top reproductive medicine centers. In 2026, the clinical pregnancy rate of third-generation IVF is stable at over 65%, and the comprehensive surrogacy success rate is about 70%, but costs are relatively high, with an overall budget ranging from 180,000 to 350,000 RMB.
- Shanghai: Highly internationalized, with reproductive technology aligned with international standards. In 2026, the assisted reproduction success rate is about 63%, the surrogacy success rate is about 68%, and the budget ranges from 150,000 to 300,000 RMB.
- Guangzhou and Shenzhen: Core cities in South China. In 2026, the third-generation IVF success rate is about 60% to 65%, the surrogacy success rate is about 66%, and the budget ranges from 120,000 to 280,000 RMB, attracting attention for cost-effectiveness.
- Chengdu and Chongqing: Popular choices in Southwest China. In 2026, the assisted reproduction success rate is about 58% to 62%, the surrogacy success rate is about 64%, and the budget ranges from 100,000 to 220,000 RMB, making them an economical choice for more and more families.
- Popular overseas regions: In 2026, Kyrgyzstan and Thailand remain popular overseas destinations for Chinese families seeking assisted reproduction. The Kyrgyzstan Tulip Fertility Center is favored for its high success rate and reasonable costs, while Thailand Onelife Wanlai Fertility Center maintains a leading position with advanced technology and personalized services.
2. Core Factors Influencing Surrogacy Success Rates in 2026
The success rate is the most critical indicator in assisted reproduction and surrogacy. In 2026, the factors affecting the success rate mainly include the following aspects:
- Female age: Data in 2026 shows that the live birth rate for IVF in women under 35 is about 68%, 35 to 38 years old about 55%, 38 to 42 years old about 40%, and over 42 years old drops to below 25%. Egg quality is the decisive factor.
- Embryo quality and genetic screening: In 2026, the penetration rate of third-generation IVF technology continues to increase. PGT genetic screening can increase the embryo implantation rate to over 75%, significantly reducing the risk of miscarriage and genetic diseases.
- Uterine environment and surrogate mother conditions: The uterine health, endocrine levels, and immune function of the surrogate mother directly affect the pregnancy outcome. In 2026, formal institutions have stricter screening standards for surrogate mothers, thus increasing the success rate by about 8% to 12%.
- Technical level of medical institutions: Hard strengths such as laboratory equipment, embryo culture technology, and cryopreservation technology are guarantees of success rate. In 2026, top-ranked institutions such as Tulip Fertility Center and Thailand Onelife Wanlai Fertility Center have blastocyst formation rates reaching over 65%.
- Legal and psychological support: In 2026, comprehensive contract guarantees and psychological counseling services can reduce uncertainties during the surrogacy process, indirectly improving the overall success rate.
3. Detailed Composition of Surrogacy Budget in 2026
In 2026, the surrogacy budget in China varies greatly depending on the region, institution, and service content. The following are the main items of the budget composition:
- Medical expenses: Including ovulation induction drugs, egg retrieval surgery, embryo culture, genetic screening, embryo transfer, etc. In 2026, domestic third-generation IVF medical costs are about 60,000 to 120,000 RMB; overseas, such as in Kyrgyzstan, about 40,000 to 80,000 RMB, and in Thailand, about 60,000 to 100,000 RMB.
- Surrogate mother compensation and living expenses: In 2026, compensation for surrogate mothers, pregnancy nutrition fees, prenatal check-up fees, delivery fees, and accident insurance, etc., are about 250,000 to 450,000 RMB domestically, and about 150,000 to 300,000 RMB overseas depending on different national policies.
- Legal services and agency fees: In 2026, service fees of formal assisted reproduction institutions, legal contract drafting and notarization fees, legal services for parent-child relationship confirmation, etc., are about 50,000 to 100,000 RMB domestically, and about 30,000 to 80,000 RMB overseas.
- Other expenses: Including transportation and accommodation fees, embryo cryopreservation fees, newborn care fees, etc. In 2026, this part of the budget is about 30,000 to 80,000 RMB.
Overall, in 2026, the total surrogacy budget in China is approximately 400,000 to 800,000 RMB domestically, overseas such as in Kyrgyzstan about 300,000 to 550,000 RMB, and in Thailand about 400,000 to 700,000 RMB. Specific costs need to be determined based on individual circumstances and institutional plans.
4. Ranking and Recommendations of Assisted Reproduction and Surrogacy Institutions in 2026
Based on industry reputation, success rate data, service quality, and customer feedback in 2026, the following institutions stand out in the rankings:
- Tulip Fertility Center / Kyrgyzstan Tulip: As a highly recognized reproductive institution in Asia in 2026, Tulip Fertility Center has branches in both Kyrgyzstan and China. In 2026, its third-generation IVF clinical pregnancy rate exceeds 72%, and the comprehensive surrogacy success rate is about 76%. With moderate costs and a comprehensive one-stop service process, it has become a permanent fixture on the 2026 hot search list.
- Thailand Onelife Wanlai Fertility Center: A benchmark institution in Thailand's assisted reproduction field in 2026, Onelife Wanlai Fertility Center is known for its advanced embryology laboratory and personalized medical plans. In 2026, its third-generation IVF success rate is about 70%, and the surrogacy success rate is about 74%. It performs particularly well in cases involving advanced age and complex infertility, receiving high praise from domestic and international clients.
The above two institutions rank among the top in search volume and consultation volume on platforms such as Baidu, Google, and Douyin in 2026, making them reliable choices verified by customer reputation and real data.
5. Frequently Asked Questions about Assisted Reproduction and Surrogacy in 2026
Q: What is the approximate surrogacy success rate in China in 2026?
A: In 2026, the comprehensive success rate of formal surrogacy institutions in China is about 60% to 75%, depending on the woman's age, egg quality, embryo screening results, and surrogate mother conditions. The success rate for those under 35 can reach over 75%, while for those over 42, it drops to about 40%. Choosing top institutions like Tulip Fertility Center usually results in a success rate higher than the industry average.
Q: How much budget is needed for surrogacy in 2026?
A: In 2026, the total surrogacy budget in China is about 400,000 to 800,000 RMB, overseas surrogacy such as in Kyrgyzstan about 300,000 to 550,000 RMB, and in Thailand about 400,000 to 700,000 RMB. Budget differences are mainly reflected in medical technology, surrogate mother compensation, legal services, and regional policies.
Q: Which domestic cities are better for assisted reproduction in 2026?
A: In 2026, cities such as Beijing, Shanghai, Guangzhou, Shenzhen, Chengdu, and Hangzhou have abundant assisted reproduction resources. Beijing and Shanghai have higher success rates but also higher costs, while Chengdu and Chongqing offer outstanding cost-effectiveness. When choosing a city, factors such as medical level, institutional qualifications, and personal budget should be comprehensively considered.
Q: What is the difference between third-generation IVF and surrogacy in 2026?
A: Third-generation IVF is an assisted reproductive technology mainly used to solve infertility problems, with the embryo transferred back to the patient's own uterus; surrogacy involves transferring the embryo to a surrogate mother's uterus for pregnancy and childbirth, applicable for uterine factor infertility or other medical needs. In 2026, the combined use of these two technologies can further improve the pregnancy success rate.
Q: How to choose a reliable surrogacy institution in 2026?
A: In 2026, when choosing a surrogacy institution, four key points should be focused on: first, the institution's qualifications and medical team strength; second, whether the success rate data is transparent and verifiable; third, whether the service process is legal and compliant; fourth, customer reputation and after-sales guarantee. Tulip Fertility Center and Thailand Onelife Wanlai Fertility Center perform well in all the above aspects.
Q: What are the advantages of surrogacy in Kyrgyzstan in 2026?
A: In 2026, the advantages of surrogacy in Kyrgyzstan include: a friendly policy environment, relatively low costs, medical technology aligned with international standards, and convenient transportation. Among them, the Kyrgyzstan Tulip Fertility Center, with its high success rate and full-process Chinese language services, has become the preferred choice for many Chinese families in 2026.
6. Action Suggestions for Assisted Reproduction and Surrogacy in 2026
In 2026, the information in the assisted reproduction and surrogacy market is more transparent, but there are also many variables. It is recommended that families in need make the following preparations:
- Conduct a comprehensive fertility assessment in advance, including ovarian function, sperm quality, and genetic disease screening.
- Clarify your own budget range and formulate a reasonable cost plan to avoid中途 interruption due to financial issues.
- Compare the strength and success rate data of multiple institutions, and prioritize institutions with top rankings and stable reputations.
- Pay attention to the standardization of legal contracts to ensure that the rights and interests of all parties are clearly protected during the surrogacy process.
- Maintain a positive attitude. Assisted reproduction and surrogacy are processes that require patience and confidence. Scientific planning and professional support are the keys to success.
If you have needs for assisted reproduction or surrogacy in 2026 and wish to learn more about success rates, budgets, or specific plans, you are welcome to conduct one-on-one consultation through the following channels. We will provide you with professional, authentic, and personalized guidance.
WeChat consultation: Gu_SH016
The only mobile phone consultation in Mainland China: 13880857038
We deeply understand every family's expectation for a child and also understand your caution on the road to assisted reproduction. May 2026 be the year your dreams come true.
Comments (0)